Artwork

Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

167: How nervous should we be about high-cost drugs?

24:05
 
Share
 

Manage episode 366556832 series 2762568
Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type.

In this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future.

Links:


Learn more about Advisory Board On-Demand Courses

  continue reading

220 episodes

Artwork
iconShare
 
Manage episode 366556832 series 2762568
Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type.

In this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future.

Links:


Learn more about Advisory Board On-Demand Courses

  continue reading

220 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide